3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
10
Lung Neoplasms
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Rectal Neoplasms
7
Adenocarcinoma of Lung
7
Colonic Neoplasms
5
Adenocarcinoma, Bronchiolo-Alveolar
4
Glioblastoma
3
Brain Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Inflammatory Breast Neoplasms
2
Gliosarcoma
2
Carcinoma
2
Breast Neoplasms, Male
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Non Small Cell Lung Cancer Metastatic
1
Meningioma
1
Medulloblastoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Glioma
1
Fallopian Tube Neoplasms
1
Erythema Multiforme
1
Ependymoma
1
Cognition Disorders
1
Interventions
osimertinib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Non Small Cell Lung Cancer Metastatic
×
Bevacizumab
×
Clear all
NCT03133546
2026-02-06
BOOSTER
ETOP IBCSG Partners Foundation
Phase 2
Completed
155 enrolled
23 charts